{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:58:51Z","timestamp":1790207931916,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EB916121"],"award-info":[{"award-number":["R01EB916121"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30CA006973"],"award-info":[{"award-number":["P30CA006973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UL1TR001079"],"award-info":[{"award-number":["UL1TR001079"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shared Instrument","award":["S10OD020091"],"award-info":[{"award-number":["S10OD020091"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001079"],"award-info":[{"award-number":["UL1 TR001079"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.biomaterials.2020.119935","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:38:48Z","timestamp":1583311128000},"page":"119935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization"],"prefix":"10.1016","volume":"243","author":[{"given":"Sean F.","family":"Hackett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Chun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Tsujinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Lima e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibran","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biomaterials.2020.119935_bib1","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archopht.1975.01010020934002","article-title":"Retinal ischemia in diabetic retinopathy","volume":"93","author":"Bresnick","year":"1975","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119935_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000308758","article-title":"Retinal ischemia (capillary nonperfusion) and retinal neovascularization in patients with diabetic retinopathy","volume":"177","author":"Merin","year":"1978","journal-title":"Ophthalmologica"},{"issue":"11","key":"10.1016\/j.biomaterials.2020.119935_bib3","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(82)34655-2","article-title":"Retinal ischemia and risk of neovascularization following central retinal vein obstruction","volume":"89","author":"Magargal","year":"1982","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119935_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1167\/iovs.03-0557","article-title":"Supplemental inspired oxygen improves diabetic macular edema; a pilot study","volume":"45","author":"Nguyen","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.119935_bib5","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119935_bib6","first-page":"182","article-title":"Hypoxia inducible factor-1a is increased in ischemic retina: temporal and spatial correlation with VEGF expression","volume":"40","author":"Ozaki","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.119935_bib7","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1","volume":"93","author":"Kelly","year":"2003","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.biomaterials.2020.119935_bib8","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.ophtha.2015.07.034","article-title":"Diabetic retinopathy severity and peripheral lesions are associated with nonperfusion on ultrawide field angiography","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119935_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jcp.20525","article-title":"Implication of the hypoxia response element of the VEGF promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development","volume":"206","author":"Vinores","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"20","key":"10.1016\/j.biomaterials.2020.119935_bib10","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-induced transcription","volume":"95","author":"Chandel","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2020.119935_bib11","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochodrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia","volume":"275","author":"Chandel","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.119935_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss","volume":"119","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biomaterials.2020.119935_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jcp.21698","article-title":"Oxidative stress promotes ocular neovascularization","volume":"219","author":"Dong","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"35","key":"10.1016\/j.biomaterials.2020.119935_bib14","doi-asserted-by":"crossref","first-page":"14614","DOI":"10.1073\/pnas.1012859108","article-title":"Vascular cell adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress","volume":"108","author":"Dong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119935_bib15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.10-6476","article-title":"Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration","volume":"52","author":"Mullins","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2020.119935_bib16","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.ajpath.2019.04.005","article-title":"Choriocapillaris degeneration in geographic atrophy","volume":"189","author":"Sohn","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"25","key":"10.1016\/j.biomaterials.2020.119935_bib17","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1364\/OE.11.003490","article-title":"In vivo dynamic human retinal blood flow imaging using ultra-high-speed spectral domain optical coherence tomography","volume":"11","author":"White","year":"2003","journal-title":"Optic Express"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119935_bib18","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1364\/OE.20.004710","article-title":"Split-spectrum amplitude-decorrelation angiography with optical coherence tomography","volume":"20","author":"Jia","year":"2012","journal-title":"Optic Express"},{"issue":"15","key":"10.1016\/j.biomaterials.2020.119935_bib19","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1167\/iovs.18-25032","article-title":"OCT angiography and cone photoreceptor imaging in geographic atrophy","volume":"59","author":"Qin","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.biomaterials.2020.119935_bib20","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/bjophthalmol-2013-303143","article-title":"Age-related macular degeneration: choroidal ischaemia?","volume":"97","author":"Coleman","year":"2013","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.119935_bib21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1096\/fj.09-145664","article-title":"Digoxin inhibits retinal ischemia-induced HIF-1alpha expression and ocular neovascularization","volume":"24","author":"Yoshida","year":"2010","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119935_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jconrel.2013.10.008","article-title":"Sustained delivery of a HIF-1 antagonist for ocular neovascularization","volume":"172","author":"Iwase","year":"2013","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119935_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00109-016-1498-9","article-title":"The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization","volume":"95","author":"Zeng","year":"2017","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.biomaterials.2020.119935_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4773(97)00674-6","article-title":"A putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1-alpha and developmentally expressed in blood vessels","volume":"63","author":"Flamme","year":"1997","journal-title":"Mech. Dev."},{"issue":"9","key":"10.1016\/j.biomaterials.2020.119935_bib25","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.94.9.4273","article-title":"A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1-alpha regulates VEGF expression and is potentially involved in lung and vascular development","volume":"94","author":"Ema","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"40","key":"10.1016\/j.biomaterials.2020.119935_bib26","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/onc.2008.160","article-title":"Hypoxia-inducible factor 2 regulates vascular tumorigenesis in mice","volume":"27","author":"Rankin","year":"2008","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.biomaterials.2020.119935_bib27","doi-asserted-by":"crossref","first-page":"17910","DOI":"10.1073\/pnas.0909353106","article-title":"Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization","volume":"106","author":"Lee","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.119935_bib28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","article-title":"Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model","volume":"153","author":"Tobe","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2020.119935_bib29","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1038\/s41598-017-14990-w","article-title":"Hif-1\u03b1-targeting acriflavine provides long term survival and radiological tumor response in brain cancer therapy","volume":"7","author":"Mangraviti","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119935_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow needles","volume":"28","author":"Patel","year":"2011","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.119935_bib31","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119935_bib32","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the Tanzanite Study","volume":"2","author":"Campochiaro","year":"2017","journal-title":"Ophthalmology Retina"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119935_bib33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archopht.1989.01070010270035","article-title":"A new model of choroidal neovascularization in the rat","volume":"107","author":"Dobi","year":"1989","journal-title":"Arch. Ophthalmol."},{"issue":"10","key":"10.1016\/j.biomaterials.2020.119935_bib34","first-page":"3158","article-title":"VEGF is an important stimulator in a model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119935_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"14","key":"10.1016\/j.biomaterials.2020.119935_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biomaterials.2020.119935_bib37","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biomaterials.2020.119935_bib38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ophtha.2011.12.016","article-title":"HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration","volume":"119","author":"Singer","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.biomaterials.2020.119935_bib39","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal Aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.biomaterials.2020.119935_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119935_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2014-305327","article-title":"Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration","volume":"99","author":"Holz","year":"2015","journal-title":"Br. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119935_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ophtha.2017.10.010","article-title":"Real-world vision in age-related macular degeneration patients treated with single anti-VEGF drug type for 1 year in the IRIS registry","volume":"125","author":"Rao","year":"2018","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.biomaterials.2020.119935_bib43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajo.2015.06.023","article-title":"Disease burden in the treatment of age-related macular degeneration: findings from a time-and-motion study","volume":"160","author":"Prenner","year":"2015","journal-title":"Am. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.biomaterials.2020.119935_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2020.119935_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/IAE.0b013e31827b6324","article-title":"Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study","volume":"33","author":"Cohen","year":"2013","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.biomaterials.2020.119935_bib46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1755-3768.2012.02493.x","article-title":"Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study- a noninterventional study of retnibizumab treatment for neovascular age-related macular degeneration in Germany","volume":"91","author":"Finger","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"20","key":"10.1016\/j.biomaterials.2020.119935_bib47","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2020.119935_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ophtha.2012.10.014","article-title":"Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration","volume":"120","author":"Busbee","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.biomaterials.2020.119935_bib49","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.biomaterials.2020.119935_bib50","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymthe.2017.12.002","article-title":"AAV8-antiVEGFfab ocular gene transfer for neovascular age-related macular degeneration","volume":"26","author":"Liu","year":"2017","journal-title":"Mol. Ther."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220301812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961220301812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:51:04Z","timestamp":1758905464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961220301812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":50,"alternative-id":["S0142961220301812"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119935","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119935"}}